Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
NXT2B AB is a venture capital firm founded in 2011 by Bengt Ågerup and is based in Uppsala, Sweden. The firm focuses on growth equity investments and has backed over 30 companies since its inception. NXT2B primarily targets sectors such as healthcare, medical devices, and specialty pharmaceuticals.
NXT2B specializes in growth equity investments in healthcare, medical devices, specialty pharmaceuticals, technology, and consumer products. The firm seeks early-phase projects that exhibit high scientific quality and viable business opportunities. Typical investments are aimed at companies that are poised for significant growth.
Notable portfolio companies include AllgoHolding AB, Hansa Biopharma AB, Lokon Pharma AB, Lumina Adhesives AB, Navinci Diagnostics AB, Q-linea AB, Repos Pharma AB, Scint-X AB, and Vivolux AB.
Email your pitch deck to info@nxt2b.com for consideration.
NXT2B often leads investment rounds, particularly in growth equity deals where they can provide significant capital and strategic support.
The firm is open to follow-on investments in portfolio companies that demonstrate continued growth and alignment with their investment thesis.
Specific fund size details are not disclosed, but NXT2B has a history of investing in multiple companies across various sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.